Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II Study of SHR-1139 Injection in Moderate-to-Severe Plaque Psoriasis
ChiCTR2600128658Phase 2Not yet recruiting
- Sponsor
- Southern Medical University Dermatology Hospital
- Start
- Jul 2026
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of SHR-1139 in plaque psoriasis (2 arms), sponsored by Southern Medical University Dermatology Hospital. Primary endpoint: Psoriasis Area and Severity Index (PASI) total score at Week 52. Planned start Jul 2026; status: not yet recruiting.
02
Drugs
SHR-1139
03
Conditions
plaque psoriasis
Beyond the preview
Go deeper on ChiCTR2600128658.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600128658.